Imagio® Breast Imaging System
Real World Use of OA Imaging Confirms Clinical Acceptability of Second Generation Imagio® Breast Imaging System
31 oct. 2024 10h00 HE | Seno Medical
San Antonio, TX, Oct. 31, 2024 (GLOBE NEWSWIRE) -- A study published in Academic Radiology, Exploring the Utility of Optoacoustic Imaging in Differentiation of Benign and Malignant Breast Masses:...
European Breast Cancer Screening Market
Europe Breast Cancer Screening Market Forecast Report and Company Analysis 2024-2032 Featuring AstraZeneca, Novartis, Sanofi, Pfizer, Bayer, and GlaxoSmithKline
04 sept. 2024 10h39 HE | Research and Markets
Dublin, Sept. 04, 2024 (GLOBE NEWSWIRE) -- The "Europe Breast Cancer Screening Market Forecast Report by Europe Breast Cancer Screening Market, Countries, and Company Analysis, 2024-2032" report has...
22157.jpg
Global Interventional Oncology Devices Market Targets Growth to $3.25 Billion by 2028
26 mars 2024 18h10 HE | Research and Markets
Dublin, March 26, 2024 (GLOBE NEWSWIRE) -- The "Interventional Oncology Devices Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Market Expansion Driven by...
The American Medical Association (AMA) has issued a new Category III Current Procedural Terminology (CPT*) code for the use of Imagio® (OA/US) Breast Imaging System, a new modality in breast cancer imaging and diagnosis by Seno Medical.
American Medical Association Issues New CPT Code for Use of Seno Medical’s Opto-acoustic Technology in Breast Cancer Diagnosis
13 févr. 2024 10h00 HE | Seno Medical
San Antonio, TX, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The American Medical Association (AMA) has issued a new Category III Current Procedural Terminology (CPT*) code for the use of Imagio® (OA/US)...
SenoGram® and the Imagio® Breast Imaging System
Seno Medical’s SenoGram® Decision Support Tool Named Winner in 2023 Artificial Intelligence Excellence Awards
23 mars 2023 09h30 HE | Seno Medical
San Antonio, TX, March 23, 2023 (GLOBE NEWSWIRE) -- The Artificial Intelligence Excellence Awards program has selected Seno Medical’s AI platform, SenoGram® — exclusively available in conjunction...
New book shares one woman’s experiences, insights and perspectives gleaned from navigating a genetically driven breast cancer diagnosis
18 nov. 2020 02h48 HE | Balboa Press
SHAKER HEIGHTS, Ohio, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Penny Casselman marks her publishing debut with the release of “How To Get A Free Boob Job” (published by Balboa Press). With sprinkles of...
Atossa Genetics' National Reference Laboratory for Breast Health Receives CLIA Certification
05 mars 2012 09h48 HE | Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - Mar 5, 2012) - Atossa Genetics, Inc., a private healthcare company focused on the prevention of breast cancer through the commercialization of diagnostic tests that can...